Morgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $40
Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:LAZ) with a Underweight and lowers the price target from $41 to $40.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga